iRadimed Q2 2024 Adj. EPS $0.42 Beats $0.36 Estimate, Sales $17.929M Beat $17.649M Estimate
Author: Benzinga Newsdesk | August 01, 2024 08:37am
iRadimed (NASDAQ:
IRMD) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.36 by 16.67 percent. The company reported quarterly sales of $17.929 million which beat the analyst consensus estimate of $17.649 million by 1.59 percent. This is a 11.15 percent increase over sales of $16.130 million the same period last year.
Posted In: IRMD